Immunome, Inc. (IMNM) vs Xencor, Inc. (XNCR)
A side-by-side comparison of Immunome, Inc. and Xencor, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IMNM
Immunome, Inc.
$19.64HealthcareDelayed quote: Oct 6, 2026, 3:40 PM EDT
XNCR
Xencor, Inc.
$24.01HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — IMNM vs XNCR
growth of $100 · dividends reinvested · last 6yIMNM +57.4% (+7.9%/yr)XNCR -30.0% (-5.8%/yr)IMNM compounded faster over this window
IMNM XNCR
IMNM vs XNCR: by the numbers
- •IMNM is the larger company ($1.88B vs $1.78B market cap).
- •Both run net losses; XNCR's is the smaller (-155.59% vs -3059.99% net margin).
Metrics side by side
Valuation
| Metric | IMNM | XNCR |
|---|---|---|
| P/S ratio | N/A | 16.96 |
| P/B ratio | 3.58 | 3.54 |
Profitability
| Metric | IMNM | XNCR |
|---|---|---|
| Gross margin | 57.43% | 91.63% |
| Operating margin | -3084.76% | -141.35% |
| Net margin | -3059.99% | -155.59% |
| ROE | -48.43% | -32.46% |
| ROIC | -51.06% | -33.60% |
Growth (annualized)
| Metric | IMNM | XNCR |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 0.47% |
| Total return CAGR (5Y) | 2.88% | -6.46% |
Frequently asked
- How have IMNM and XNCR total returns compared?
- Over the past 5 years, IMNM delivered 2.88% and XNCR delivered -6.46% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.